Our investigation commenced with an enrichment analysis of ADAR-KO teratomas, unveiling a pan-teratoma reduction in ADAR-expressing cells (Supplementary Fig. 8A) and discernible variations in cell type compositions across perturbations (Supplementary Fig. 8C). The gene discussed is ADAR; the disease is teratoma.